Novacyt SA (AIM:NCYT, OTC:NVYTF, EPA:ALNOV) said its real-time PCR test has been approved in the UK.
The PROmate COVID-19 1G test is the company's second direct-to-PCR and third product to be added to the UK's official register of approved products.
Novacyt said it is awaiting further updates on five other products submitted to the Coronavirus Test Device Approvals across its COVID-19 testing portfolio.